.png)
Back
Appropriate use of the new β-lactam β-lactamase inhibitor combinations in SA
Prof. Adrian Brink | Clinical
Sharing a strategic categorization of mechanism-based inhibition of β-lactamases (new BLICs) and appropriate use of the new β-lactam β-lactamase in
| Topic / Title of the Talk | Appropriate use of the new β-lactam β-lactamase inhibitor combinations in SA |
| Field of Medicine | Microbiology |
| Length of the Talk | 30 Mins |
| CPD Accreditation No. | MDB015/MPDP/070/871 |
| Category of the Talk | Overview |
| CPD Type | Clinical |
| Languages (Translations) & Subtitles | Not Translated |
| Speaker | Prof. Adrian Brink |
Talk Description
Sharing a strategic categorization of mechanism-based inhibition of β-lactamases (new BLICs) and appropriate use of the new β-lactam β-lactamase inhibitor combinations, Ceftazidime-avibactam and Ceftolozane-tazobactam, in South Africa.
Medtalkz Webinar - May 2022
Medtalkz Webinar - May 2022
Related Talkz
